ArticleClinical case reports2025

First Report of Trametinib-Nintedanib Combination in KRAS G12D-Mutated Pancreatic Cancer: Efficacy and Fatal Hemorrhagic Complication: A Case Report.

Yufei Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.